These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2609647)

  • 1. [Lassa and Mozambique viruses: cross protection in experiments on mice and action of immunosuppressants on experimental infections].
    Barkar ND; Lukashevich IS
    Vopr Virusol; 1989; 34(5):598-603. PubMed ID: 2609647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of immunosuppression on the development and outcome of an acute infection in mice caused by administration of the Lassa virus].
    Barkar ND; Mar'iankova RF; Godneva AT; Grigor'eva LV; Zudin BI
    Vopr Virusol; 1989; 34(2):208-13. PubMed ID: 2763513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathogenicity of the Lassa virus for laboratory mice].
    Lukashevich IS; Orlova SV; Mar'iankova RF; Barkar ND
    Vopr Virusol; 1985; 30(5):595-9. PubMed ID: 4072162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunogenic and protective characteristics of recombinant Lassa virus NP protein].
    Ignat'ev GM
    Vopr Virusol; 2002; 47(2):28-31. PubMed ID: 12046464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses.
    Lukashevich IS; Patterson J; Carrion R; Moshkoff D; Ticer A; Zapata J; Brasky K; Geiger R; Hubbard GB; Bryant J; Salvato MS
    J Virol; 2005 Nov; 79(22):13934-42. PubMed ID: 16254329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zidampidine, an aryl phosphate derivative of AZT: in vivo pharmacokinetics, metabolism, toxicity, and anti-viral efficacy against hemorrhagic fever caused by Lassa virus.
    Uckun FM; Venkatachalam TK; Erbeck D; Chen CL; Petkevich AS; Vassilev A
    Bioorg Med Chem; 2005 May; 13(9):3279-88. PubMed ID: 15809163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute and chronic Lassa virus infection of Vero cells].
    Lukashevich IS; Mar'iankova RF; Fidarov FM
    Vopr Virusol; 1981; (4):452-6. PubMed ID: 7303630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset.
    Safronetz D; Rosenke K; Westover JB; Martellaro C; Okumura A; Furuta Y; Geisbert J; Saturday G; Komeno T; Geisbert TW; Feldmann H; Gowen BB
    Sci Rep; 2015 Oct; 5():14775. PubMed ID: 26456301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Research with the Marburg, Lassa and Ebola viruses].
    Pshenichnov VA; Makhlaĭ AA; Mikhaĭlov VV
    Vopr Virusol; 1993; 38(2):54-8. PubMed ID: 8059520
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dynamics of antigen and antibody accumulation in adult mice, infected with Lassa virus].
    Vladyko AS; Surikova LE; Kramarenko LP; Bystrova SI; Torop AV
    Vopr Virusol; 1989; 34(1):100-3. PubMed ID: 2658319
    [No Abstract]   [Full Text] [Related]  

  • 11. Protection of Lassa virus-infected guinea pigs with Lassa-immune plasma of guinea pig, primate, and human origin.
    Jahrling PB
    J Med Virol; 1983; 12(2):93-102. PubMed ID: 6619814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The dynamics of the formation of IgG subclasses in Balb/c and CBA mice infected with the LCM, Lassa and Mopeia viruses and their role in diagnosis].
    Zaĭtseva VN; Bystrova SI; Shkolina TV; Vladyko AS
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (1):47-51. PubMed ID: 9221657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive antibody therapy of Lassa fever in cynomolgus monkeys: importance of neutralizing antibody and Lassa virus strain.
    Jahrling PB; Peters CJ
    Infect Immun; 1984 May; 44(2):528-33. PubMed ID: 6715049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental infection of rhesus monkeys with Lassa virus and a closely related arenavirus, Mozambique virus.
    Walker DH; Johnson KM; Lange JV; Gardner JJ; Kiley MP; McCormick JB
    J Infect Dis; 1982 Sep; 146(3):360-8. PubMed ID: 6286795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation between two African arenaviruses (Lassa and Mozambique) by plaque assay.
    Tomori O; Johnson K
    Acta Virol; 1987 Mar; 31(2):146-51. PubMed ID: 2886023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation in vitro and in vivo of an attenuated Lassa vaccine candidate.
    Zapata JC; Goicochea M; Nadai Y; Eyzaguirre LM; Carr JK; Tallon LJ; Sadzewicz L; Myers G; Fraser CM; Su Q; Djavani M; Lukashevich IS; Salvato MS
    J Virol; 2014 Mar; 88(6):3058-66. PubMed ID: 24335292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental Lassa infection in monkeys and its treatment with ribamidil].
    Fidarov FM; Sabynin VM; Petkevich AS; Surikova LE; Vladyko AS; Lukashevich IS
    Vopr Virusol; 1990; 35(6):504-6. PubMed ID: 2082557
    [No Abstract]   [Full Text] [Related]  

  • 18. Stampidine prevents mortality in an experimental mouse model of viral hemorrhagic fever caused by lassa virus.
    Uckun FM; Petkevich AS; Vassilev AO; Tibbles HE; Titov L
    BMC Infect Dis; 2004 Jan; 4():1. PubMed ID: 14720304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a new vaccine for the prevention of Lassa fever.
    Geisbert TW; Jones S; Fritz EA; Shurtleff AC; Geisbert JB; Liebscher R; Grolla A; Ströher U; Fernando L; Daddario KM; Guttieri MC; Mothé BR; Larsen T; Hensley LE; Jahrling PB; Feldmann H
    PLoS Med; 2005 Jun; 2(6):e183. PubMed ID: 15971954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endemic Lassa fever in Liberia. III. Characterization of Lassa virus isolates.
    Jahrling PB; Frame JD; Smith SB; Monson MH
    Trans R Soc Trop Med Hyg; 1985; 79(3):374-9. PubMed ID: 3898483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.